AWH Stock Summary and Trading Ideas (Aspira Womens Health | NASDAQ:AWH)

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

Aspira Womens Health trades on the NASDAQ stock market under the symbol AWH.

As of April 25, 2024, AWH stock price declined to $3.28 with 6,351 million shares trading.

AWH has a beta of 1.38, meaning it tends to be more sensitive to market movements. AWH has a correlation of 0.02 to the broad based SPY ETF.

AWH has a market cap of $40.49 million. This is considered a Sub-Micro Cap stock.

Last quarter Aspira Womens Health reported $2 million in Revenue and -$.30 earnings per share. This fell short of revenue expectation by $-410,000 and exceeded earnings estimates by $.15.

In the last 3 years, AWH stock traded as high as $93.75 and as low as $2.31.

The top ETF exchange traded funds that AWH belongs to (by Net Assets): VTI, VXF.

AWH has underperformed the market in the last year with a return of -37.5%, while the SPY ETF gained +25.6%. In the last 3 month period, AWH fell short of the market, returning -23.5%, while SPY returned +3.5%. However, in the most recent 2 weeks AWH has outperformed the stock market by returning +1.9%, while SPY returned -2.8%.

AWH support price is $3.13 and resistance is $3.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AWH stock will trade within this expected range on the day.